Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
vivani leverages proprietary technologies to develop and commercialize drug and device implants, including its lead asset npm-119 (exenatide implant), which seeks to treat patients with chronic diseases with high unmet medical need.